Announcements Trials
Browse Landscape

Phase

Phase 1 9Phase 2 4Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 19Myelodysplastic Syndromes 3Leukemia, Myelomonocytic, Chronic 3Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Pathologic Complete Response 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Lymphoma, T-Cell, Peripheral 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia 1Congenital Abnormalities 1Anemia, Refractory, with Excess of Blasts 1Anemia, Refractory 1

Interventions

Cytarabine 13Daunorubicin 11Etoposide 7Filgrastim 5Peripheral Blood Stem Cell Transplantation 4Gemtuzumab 4valspodar 3Observation 3Mitoxantrone 3Busulfan 3sargramostim 2fludarabine phosphate 2aldesleukin 2Tretinoin 2Therapeutics 2Idarubicin 2Granulocyte Colony-Stimulating Factor 2Early Intervention, Educational 2Cyclophosphamide 2zosuquidar trihydrochloride 1midostaurin 1merphos 1laromustine 1etoposide phosphate 1dexamethasone acetate 1Whole-Body Irradiation 1Watchful Waiting 1Thioguanine 1Tacrolimus 1Radiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Congenital Abnormalities × Decitabine × Clear all
NCT02085408 2024-12-13

Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia

Eastern Cooperative Oncology Group

Phase 3 Completed
727 enrolled 13 charts
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡